{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:47:04Z","timestamp":1787510824978,"version":"build-2736575974"},"reference-count":99,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","cidjournal.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.clindermatol.2016.10.018","type":"journal-article","created":{"date-parts":[[2016,10,27]],"date-time":"2016-10-27T18:45:13Z","timestamp":1477593913000},"page":"218-224","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Treatments for hidradenitis suppurativa"],"prefix":"10.1016","volume":"35","author":[{"given":"R. Kj\u00e6rsgaard","family":"Andersen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregor B.E.","family":"Jemec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2016.10.018_bb0005","doi-asserted-by":"publisher","DOI":"10.1007\/s11154-016-9328-5","article-title":"Evidence-based approach to the treatment of hidradenitis suppurativa\/acne inversa, based on the European guidelines for hidradenitis suppurativa","author":"Gulliver","year":"2016","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0010","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1111\/jdv.12966","article-title":"European S1 for the treatment of hidradenitis suppurativa\/acne inversa","volume":"29","author":"Zouboulis","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0015","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1056\/NEJMcp1014163","article-title":"Clinical practice. Hidradenitis suppurativa","volume":"366","author":"Jemec","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0020","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1159\/000431175","article-title":"Hidradenitis suppurativa\/acne inversa: criteria for diagnosis, severity assessment, classification and disease evaluation","volume":"231","author":"Zouboulis","year":"2015","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0025","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1111\/bjd.14038","article-title":"Diagnostic delay in hidradenitis suppurativa is a global problem","volume":"173","author":"Saunte","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0030","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1016\/j.jaad.2015.07.052","article-title":"Hidradenitis suppurativa: epidemiology and scope of the problem","volume":"73","author":"Jemec","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0035","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0190-9622(96)90321-7","article-title":"The prevalence of hidradenitis suppurativa and its potential precursor lesions","volume":"35","author":"Jemec","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0040","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1111\/bjd.14024","article-title":"Cardiovascular disease risk factors in patients with hidradenitis suppurativa: a systematic review and meta-analysis of observational studies","volume":"173","author":"Tzellos","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0045","first-page":"730","article-title":"Incidence of cancer among patients with hidradenitis suppurativa","volume":"137","author":"Lapins","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0050","first-page":"1","article-title":"Characterization of obesity rates for dermatologic ambulatory office visits to United States physicians","author":"Fleischer","year":"2016","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0055","doi-asserted-by":"publisher","first-page":"147","DOI":"10.5021\/ad.2016.28.2.147","article-title":"Management of hidradenitis suppurativa in patients with metabolic comorbidities","volume":"28","author":"Lim","year":"2016","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0060","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1111\/jdv.13522","article-title":"Body composition and basal metabolic rate in Hidradenitis Suppurativa: a Danish population-based and hospital-based cross-sectional study","volume":"30","author":"Miller","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0065","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1159\/000439562","article-title":"Coexistence of hidradenitis suppurativa with autoimmune thyroiditis: report of three cases","volume":"232","author":"Gonzalez-Lopez","year":"2016","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0070","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/bjd.13777","article-title":"Hidradenitis suppurativa and metabolic syndrome: a comparative cross-sectional study of 3207 patients","volume":"173","author":"Shalom","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0075","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1001\/jamadermatol.2014.1165","article-title":"Association of metabolic syndrome and hidradenitis suppurativa","volume":"150","author":"Miller","year":"2014","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0080","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1016\/j.jaad.2014.09.012","article-title":"Hidradenitis suppurativa is a systemic disease with substantial comorbidity burden: a chart-verified case-control analysis","volume":"71","author":"Shlyankevich","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0085","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.jaad.2013.11.014","article-title":"The prevalence of metabolic syndrome in patients with hidradenitis suppurativa","volume":"70","author":"Gold","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0090","doi-asserted-by":"crossref","first-page":"18558","DOI":"10.5070\/D3196018558","article-title":"Diseases associated with hidranitis suppurativa: part 2 of a series on hidradenitis","volume":"19","author":"Scheinfeld","year":"2013","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0095","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1111\/j.1600-0625.2012.01552.x","article-title":"Hidradenitis suppurativa: viewpoint on clinical phenotyping, pathogenesis and novel treatments","volume":"21","author":"van der Zee","year":"2012","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0100","doi-asserted-by":"publisher","first-page":"e31810","DOI":"10.1371\/journal.pone.0031810","article-title":"Increased prevalence of metabolic syndrome in patients with acne inversa","volume":"7","author":"Sabat","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0105","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.jaad.2008.06.020","article-title":"Prevalence and factors associated with hidradenitis suppurativa: results from two case-control studies","volume":"59","author":"Revuz","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0110","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1001\/jamadermatol.2015.4593","article-title":"Factors associated with point-of-care treatment decisions for hidradenitis suppurativa","volume":"152","author":"Garg","year":"2016","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0115","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.det.2015.07.003","article-title":"The handicap of hidradenitis suppurativa","volume":"34","author":"Deckers","year":"2016","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0120","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1111\/bjd.13090","article-title":"Risk factors, clinical course and long-term prognosis in hidradenitis suppurativa: a cross-sectional study","volume":"171","author":"Kromann","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0125","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/jdv.12567","article-title":"Psychiatric comorbidities in 3207 patients with hidradenitis suppurativa","volume":"29","author":"Shavit","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0130","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/j.1468-3083.2012.04468.x","article-title":"Depression in patients with hidradenitis suppurativa","volume":"27","author":"Onderdijk","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0135","doi-asserted-by":"publisher","first-page":"328","DOI":"10.2340\/00015555-1082","article-title":"Psychosocial impact of hidradenitis suppurativa: a qualitative study","volume":"91","author":"Esmann","year":"2011","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0140","doi-asserted-by":"publisher","first-page":"264","DOI":"10.2340\/00015555-0866","article-title":"Psychophysical aspects of hidradenitis suppurativa","volume":"90","author":"Matusiak","year":"2010","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0145","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1111\/j.1365-2133.2009.09198.x","article-title":"Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity","volume":"161","author":"Sartorius","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0150","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1111\/j.1468-3083.2009.03356.x","article-title":"Hidradenitis suppurativa","volume":"23","author":"Revuz","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0155","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1159\/000443878","article-title":"The ABC of hidradenitis suppurativa: a validated glossary on how to name lesions","volume":"232","author":"Lipsker","year":"2016","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0160","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1111\/j.1365-2133.1996.tb03880.x","article-title":"Hidradenitis suppurativa or acne inversa. A clinicopathological study of early lesions","volume":"135","author":"Boer","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0165","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.det.2015.08.003","article-title":"Imaging of hidradenitis suppurativa","volume":"34","author":"Wortsman","year":"2016","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0170","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0001-7310(16)30007-2","article-title":"Ultrasound examination of hidradenitis suppurativa","volume":"106","author":"Martorell","year":"2015","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0175","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1111\/dsu.12329","article-title":"Ultrasound in-depth characterization and staging of hidradenitis suppurativa","volume":"39","author":"Wortsman","year":"2013","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0180","doi-asserted-by":"crossref","first-page":"18564","DOI":"10.5070\/D3196018564","article-title":"A 3-D ultrasound study of sinus tract formation in hidradenitis suppurativa","volume":"19","author":"Wortsman","year":"2013","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0185","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1111\/j.1365-2133.2010.09710.x","article-title":"Ultrasound aids in diagnosis and severity assessment of hidradenitis suppurativa","volume":"162","author":"Kelekis","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0190","first-page":"1340","article-title":"Real-time compound imaging ultrasound of hidradenitis suppurativa","volume":"33","author":"Wortsman","year":"2007","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0195","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.det.2015.08.010","article-title":"The microbiology of hidradenitis suppurativa","volume":"34","author":"Ring","year":"2016","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0200","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1016\/j.jaad.2015.07.041","article-title":"Bacteriology of hidradenitis suppurativa\/acne inversa: a review","volume":"73","author":"Nikolakis","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0205","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.3201\/eid2012.140064","article-title":"Bacterial pathogens associated with hidradenitis suppurativa, France","volume":"20","author":"Guet-Revillet","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0210","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/j.1365-4362.1983.tb02150.x","article-title":"Topical treatment of hidradenitis suppurativa with clindamycin","volume":"22","author":"Clemmensen","year":"1983","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0215","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/S0190-9622(98)70272-5","article-title":"Topical clindamycin versus systemic tetracycline in the treatment of hidradenitis suppurativa","volume":"39","author":"Jemec","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0220","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.annder.2012.05.016","article-title":"Antibiotic treatment of hidradenitis suppurativa","volume":"139","author":"Revuz","year":"2012","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0225","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/jdv.12127","article-title":"Oral clindamycin and rifampicin in the treatment of hidradenitis suppurativa-acne inversa: a prospective study on 23 patients","volume":"28","author":"Bettoli","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0230","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.jaad.2010.09.775","article-title":"Rifampicin and clindamycin for hidradenitis","volume":"64","author":"Wall","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0235","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1159\/000228337","article-title":"The effect of combined treatment with oral clindamycin and oral rifampicin in patients with hidradenitis suppurativa","volume":"219","author":"van der Zee","year":"2009","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0240","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1159\/000228334","article-title":"Combination therapy with clindamycin and rifampicin for hidradenitis suppurativa: a series of 116 consecutive patients","volume":"219","author":"Gener","year":"2009","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0245","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1111\/j.1365-2133.2006.07155.x","article-title":"Clindamycin and rifampicin combination therapy for hidradenitis suppurativa","volume":"154","author":"Mendonca","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0250","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1684\/ejd.2013.2213","article-title":"Dramatic reduction of clindamycin plasma concentration in hidradenitis suppurativa patients treated with the rifampin-clindamycin combination","volume":"24","author":"Join-Lambert","year":"2014","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0255","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1159\/000321716","article-title":"Efficacy of rifampin-moxifloxacin-metronidazole combination therapy in hidradenitis suppurativa","volume":"222","author":"Join-Lambert","year":"2011","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0260","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1093\/jac\/dkv361","article-title":"Efficacy of ertapenem in severe hidradenitis suppurativa: a pilot study in a cohort of 30 consecutive patients","volume":"71","author":"Join-Lambert","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0265","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1159\/000329023","article-title":"Dapsone therapy for hidradenitis suppurativa: a series of 24 patients","volume":"222","author":"Yazdanyar","year":"2011","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0270","first-page":"11","article-title":"Hidradenitis suppurativa intralesional injections with corticosteroids-HILIC","volume":"25","author":"Riis","year":"2016","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0275","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1097\/00054725-200111000-00008","article-title":"Hidradenitis suppurativa and Crohn\u2019s disease: response to treatment with infliximab","volume":"7","author":"Martinez","year":"2001","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0280","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1001\/archdermatol.2010.72","article-title":"Treatment of hidradenitis suppurativa with etanercept injection","volume":"146","author":"Adams","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0285","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1111\/bjd.14418","article-title":"Interventions for hidradenitis suppurativa: a Cochrane systematic review incorporating GRADE assessment of evidence quality","volume":"174","author":"Ingram","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0290","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/j.1365-2133.2011.10339.x","article-title":"A double-blind placebo-controlled randomized trial of adalimumab in the treatment of hidradenitis suppurativa","volume":"165","author":"Miller","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0295","doi-asserted-by":"publisher","first-page":"846","DOI":"10.7326\/0003-4819-157-12-201212180-00004","article-title":"Adalimumab for the treatment of moderate to severe Hidradenitis suppurativa: a parallel randomized trial","volume":"157","author":"Kimball","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0300","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1111\/jdv.13216","article-title":"HiSCR (Hidradenitis Suppurativa Clinical Response): a novel clinical endpoint to evaluate therapeutic outcomes in patients with hidradenitis suppurativa from the placebo-controlled portion of a phase 2 adalimumab study","volume":"30","author":"Kimball","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0305","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1111\/bjd.13270","article-title":"Assessing the validity, responsiveness and meaningfulness of the Hidradenitis Suppurativa Clinical Response (HiSCR) as the clinical endpoint for hidradenitis suppurativa treatment","volume":"171","author":"Kimball","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0310","doi-asserted-by":"publisher","first-page":"AB60","DOI":"10.1016\/j.jaad.2015.02.251","article-title":"Safety and efficacy of adalimumab in patients with moderate to severe hidradenitis suppurativa: results from first 12 weeks of PIONEER I, a phase 3, randomized, placebo-controlled trial","volume":"72","author":"Kimball","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0315","doi-asserted-by":"publisher","first-page":"AB45","DOI":"10.1016\/j.jaad.2015.02.192","article-title":"Efficacy and safety of adalimumab in patients with moderate to severe hidradenitis suppurativa: Results from PIONEER II, a phase 3, randomized, placebo-controlled trial","volume":"72","author":"Jemec","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0320","doi-asserted-by":"publisher","first-page":"AB38","DOI":"10.1016\/j.jaad.2015.02.166","article-title":"Adalimumab improves health-related quality of life (HRQoL) in patients with moderate to severe hidradenitis suppurativa (HS): results from the first 12 weeks of PIONEER II","volume":"72","author":"Armstrong","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0325","first-page":"AB39","article-title":"Adalimumab improves treatment satisfaction with medication (TS-M) in patients with moderate to severe hidradenitis suppurativa (HS) in a 12-week randomized controlled trial (PIONEER II)","volume":"72","author":"Jemec","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0330","first-page":"AB39","article-title":"Adalimumab is associated with reduced skin pain in patients with moderate to severe hidradenitis suppurativa (HS): results from the first 12 weeks of PIONEER II","volume":"72","author":"Kimball","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0335","first-page":"S31","article-title":"Adalimumab improves treatment satisfaction with medication (TS-M) in patients with moderate to severe hidradenitis suppurativa (HS) in a 12-week randomised controlled trial (PIONEER I)","volume":"134","author":"Jemec","year":"2014","journal-title":"J Investig Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0340","first-page":"S34","article-title":"HUMIRA improves health-related quality of life (HRQoL) in patients with moderate to severe hidradenitis suppurativa (HS): results from the first 12 weeks of PIONEER I","volume":"134","author":"Armstrong","year":"2014","journal-title":"J Investig Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0345","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1111\/bjd.13292","article-title":"Two cases of severe hidradenitis suppurativa with failure of anakinra therapy","volume":"172","author":"Menis","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0350","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.jaad.2013.09.044","article-title":"An open-label study of anakinra for the treatment of moderate to severe hidradenitis suppurativa","volume":"70","author":"Leslie","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0355","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1001\/jamadermatol.2013.5377","article-title":"Successful treatment of severe hidradenitis suppurativa with anakinra","volume":"149","author":"Zarchi","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0360","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1159\/000343221","article-title":"Failure of anti-interleukin-1 therapy in severe hidradenitis suppurativa: a case report","volume":"226","author":"van der Zee","year":"2013","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0365","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1001\/jamadermatol.2015.3903","article-title":"Safety and Efficacy of Anakinra in Severe Hidradenitis Suppurativa: A Randomized Clinical Trial","volume":"152","author":"Tzanetakou","year":"2016","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0370","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3109\/09546634.2015.1088128","article-title":"Cyclosporine treatment of severe hidradenitis suppurativa\u2014a case series","volume":"27","author":"Anderson","year":"2016","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0375","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s00266-008-9152-8","article-title":"Intralesional triamcinolone acetonide for keloid treatment: a systematic review","volume":"32","author":"Hochman","year":"2008","journal-title":"Aesthet Plast Surg"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0380","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1471-5945-12-9","article-title":"A review of wide surgical excision of hidradenitis suppurativa","volume":"12","author":"Alharbi","year":"2012","journal-title":"BMC Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0385","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1111\/j.1524-4725.2011.02186.x","article-title":"Hidradenitis suppurativa: surgical and other management techniques","volume":"38","author":"Ellis","year":"2012","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0390","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.bjps.2015.12.004","article-title":"Wide excision and healing by secondary intent for the surgical treatment of hidradenitis suppurativa: a single-center experience","volume":"69","author":"Humphries","year":"2016","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0395","doi-asserted-by":"publisher","first-page":"S70","DOI":"10.1016\/j.jaad.2015.07.044","article-title":"Recurrence of hidradenitis suppurativa after surgical management: a systematic review and meta-analysis","volume":"73","author":"Mehdizadeh","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0400","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1097\/DSS.0000000000000264","article-title":"Recurrence rate and patient satisfaction of CO2 laser evaporation of lesions in patients with hidradenitis suppurativa: a retrospective study","volume":"41","author":"Mikkelsen","year":"2015","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0405","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1111\/j.1468-3083.2012.04646.x","article-title":"Secondary intention healing in skin surgery: our own experience and expanded indications in hidradenitis suppurativa, rhinophyma and non-melanoma skin cancers","volume":"27","author":"Bieniek","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0410","first-page":"235","article-title":"A comparison of skin grafting and healing by granulation, following axillary excision for hidradenitis suppurativa","volume":"65","author":"Morgan","year":"1983","journal-title":"Ann R Coll Surg Engl"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0415","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1002\/bjs.1800670416","article-title":"The use of silastic foam dressing in the treatment of advanced hidradenitis suppurativa","volume":"67","author":"Morgan","year":"1980","journal-title":"Br J Surg"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0420","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1046\/j.1524-4725.2000.00043.x","article-title":"Long-term results of wide surgical excision in 106 patients with hidradenitis suppurativa","volume":"26","author":"Rompel","year":"2000","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0425","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1111\/jdv.12610","article-title":"Pain and inflammation in hidradenitis suppurativa correspond to morphological changes identified by high-frequency ultrasound","volume":"29","author":"Zarchi","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0430","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1111\/j.1468-3083.2011.04203.x","article-title":"Mild to moderate hidradenitis suppurativa treated with local excision and primary closure","volume":"26","author":"van Rappard","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0435","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/S0190-9622(88)70113-9","article-title":"Effect of localized surgical excisions in hidradenitis suppurativa","volume":"18","author":"Jemec","year":"1988","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0440","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1097\/DSS.0000000000000609","article-title":"Deroofing: an effective method for treating chronic diffuse hidradenitis suppurativa","volume":"42","author":"Lin","year":"2016","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0445","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.det.2015.08.007","article-title":"Surgical procedures in hidradenitis suppurativa","volume":"34","author":"Janse","year":"2016","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0450","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1111\/j.1524-4725.2011.02255.x","article-title":"Surgical treatment of sinuses by deroofing in hidradenitis suppurativa","volume":"38","author":"van Hattem","year":"2012","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0455","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.jaad.2009.12.018","article-title":"Deroofing: a tissue-saving surgical technique for the treatment of mild to moderate hidradenitis suppurativa lesions","volume":"63","author":"van der Zee","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0460","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1097\/DSS.0000000000000637","article-title":"Surgical treatment of chronic hidradenitis suppurativa: CO2 laser stripping-second intention technique","volume":"42","author":"Crocco","year":"2016","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0465","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1111\/j.1365-2133.2008.08932.x","article-title":"Outcomes of treatment of nine cases of recalcitrant severe hidradenitis suppurativa with carbon dioxide laser","volume":"159","author":"Madan","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0470","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1111\/j.1365-2133.1994.tb08559.x","article-title":"Surgical treatment of chronic hidradenitis suppurativa: CO2 laser stripping-secondary intention technique","volume":"131","author":"Lapins","year":"1994","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0475","first-page":"941","article-title":"Therapy of suppurative hidradenitis using the CO2-laser. Case report and literature review","volume":"82","author":"Bratschi","year":"1993","journal-title":"Schweiz Rundsch Med Prax"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0480","doi-asserted-by":"publisher","first-page":"2","DOI":"10.4103\/2229-5178.105454","article-title":"Acne inversa (hidradenitis suppurativa): a review with a focus on pathogenesis and treatment","volume":"4","author":"Wollina","year":"2013","journal-title":"Indian Dermatol Online J"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0485","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1111\/j.1524-4725.2011.02157.x","article-title":"Management of severe anogenital acne inversa (hidradenitis suppurativa)","volume":"38","author":"Wollina","year":"2012","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0490","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.jaad.2014.11.039","article-title":"Chronic pain management in dermatology: a guide to assessment and nonopioid pharmacotherapy","volume":"73","author":"Enamandram","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.018_bb0495","doi-asserted-by":"crossref","first-page":"20616","DOI":"10.5070\/D31911020616","article-title":"Treatment of hidradenitis supprurativa associated pain with nonsteroidal anti-inflammatory drugs, acetaminophen, celecoxib, gabapentin, pegabalin, duloxetine, and venlafaxine","volume":"19","author":"Scheinfeld","year":"2013","journal-title":"Dermatol Online J"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X16302796?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X16302796?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,11]],"date-time":"2022-07-11T13:34:26Z","timestamp":1657546466000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X16302796"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":99,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S0738081X16302796"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2016.10.018","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatments for hidradenitis suppurativa","name":"articletitle","label":"Article Title"},{"value":"Clinics in Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clindermatol.2016.10.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}